Compounds > salmeterol xinafoate
Page last updated: 2024-08-16

salmeterol xinafoate and Drug Withdrawal Symptoms

salmeterol xinafoate has been researched along with Drug Withdrawal Symptoms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, J; Calverley, P; Gulsvik, A; Jones, P; Maden, C; Pauwels, R; Pride, N; Vestbo, J1
Vestbo, J1
Creutzberg, EC; Fokkens, B; Hensing, CA; Hop, WC; Kuipers, AF; Pasma, HR; Postma, DS; Prins, J; Wouters, EF1

Trials

3 trial(s) available for salmeterol xinafoate and Drug Withdrawal Symptoms

ArticleYear
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.
    Lancet (London, England), 2003, Feb-08, Volume: 361, Issue:9356

    Topics: Adrenergic beta-Agonists; Aged; Albuterol; Androstadienes; Anti-Inflammatory Agents; Contusions; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluticasone; Follow-Up Studies; Forced Expiratory Volume; Humans; Hydrocortisone; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Substance Withdrawal Syndrome

2003
[Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease].
    Ugeskrift for laeger, 2004, Jan-19, Volume: 166, Issue:4

    Topics: Adrenergic beta-Agonists; Aged; Albuterol; Androstadienes; Anti-Inflammatory Agents; Contusions; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluticasone; Follow-Up Studies; Forced Expiratory Volume; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Substance Withdrawal Syndrome

2004
Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial.
    Thorax, 2005, Volume: 60, Issue:6

    Topics: Administration, Inhalation; Albuterol; Analysis of Variance; Androstadienes; Bronchodilator Agents; Double-Blind Method; Drug Combinations; Female; Fluticasone; Humans; Male; Medical Records; Middle Aged; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Salmeterol Xinafoate; Substance Withdrawal Syndrome

2005